Skip to main content
European Journal of Case Reports in Internal Medicine logoLink to European Journal of Case Reports in Internal Medicine
. 2020 Dec 18;7(12):002128. doi: 10.12890/2020_002128

Primary Malignant Mesothelioma of the Liver: Case Report and Review of the Literature

Subash Ghimire 1,, Nilisha Regmi 2, Tsujung Yang 1, Harshil Shah 1, Ukorn Srivatana 1, Ashit Sarker 1, Hafiz Khan 1
PMCID: PMC7875602  PMID: 33585331

Abstract

Introduction

Primary malignant mesothelioma of the liver is an extremely rare cancer, with only 16 cases reported in the literature so far. Diagnosis is challenging due to morphological similarity with common liver cancers and the extreme rarity of the condition.

Case description

We present the case of a 70-year-old man who was found to have an incidental liver mass which was diagnosed as primary malignant mesothelioma of the liver.

Conclusion

Our report describes the presentation of this rare liver malignancy and the challenges associated with diagnosis and treatment.

LEARNING POINTS

  • Primary malignant mesothelioma of the liver is an extremely rare condition.

  • This diagnosis should be considered during the evaluation and treatment of a liver mass.

Keywords: Primary malignant mesothelioma, liver cancer, asbestosis

INTRODUCTION

Primary malignant mesothelioma of the liver is an extremely rare tumour with only 16 previously reported cases. Although asbestos exposure has been linked to 80% of cases of pleural mesothelioma and to 33–50% of cases of peritoneal mesothelioma, an association between asbestos exposure and hepatic mesothelioma has not yet been established. Hepatic mesothelioma is not currently listed in the WHO classification of hepatic tumours [1].

We present a case of primary intrahepatic mesothelioma in a 70-year-old man with asbestos exposure and provide a literature review of the cases reported to date.

CASE DESCRIPTION

A 70-year-old male patient was being followed up at our hospital for pulmonary asbestosis with an annual low-dose CT scan, when an incidental liver mass was detected. His previous CT scan had shown evidence of a stable calcified pleural plaque with no pleural or hepatic lesions. He was completely asymptomatic and showed no signs of jaundice or right upper quadrant tenderness [2].

A CT scan of the abdomen with contrast was obtained and showed a well-defined 8 cm mass with heterogenous enhancement involving the right lobe of the liver, predominantly segment VI (Fig. 1). The hepatic vein and portal vein were patent. Since the mass was highly suggestive of malignancy, a detailed work-up was planned. A chest CT scan did not show any evidence of haematogenous metastasis or pleural involvement. Laboratory findings showed liver function tests and alfa fetoprotein (AFP) within normal ranges. The viral markers for hepatitis B and hepatitis C were negative.

Figure 1.

Figure 1

CT scan showing an 8 cm mass in the liver

The patient underwent surgical resection with partial hepatectomy (segments V/VI) and cholecystectomy; part of the diaphragm was also resected. Biopsy of the liver mass showed poorly differentiated malignancy with areas of epithelioid and spindle cell differentiation (Fig. 2). Immunohistochemically, tumour cells were positive for keratin AE1/AE3, keratin CAM 5.2, WT1, calretinin, CK20 and D2–40, but negative for CD34, arginase, CK5/6, CK7, ERG, mucicarmine, MOC 31, BerEp4, desmin, S–100, and albumin in situ hybridization. The overall morphology as well as immunohistochemical staining were most consistent with poorly differentiated malignant mesothelioma.

Figure 2.

Figure 2

Tumour cells showing epithelioid (A) and spindle cell

(B) differentiation (H&E stain, ×400)

After surgery, the patient was started on four cycles of pemetrexed and cisplatin as adjuvant therapy, while being monitored for signs of relapse or distant metastasis. So far, there has been no evidence of any new lesions or metastasis, 15 months after surgery.

DISCUSSION

Primary intrahepatic mesothelioma (PIHMM) is an extremely rare tumour with only 16 cases reported in the literature to date [3]. Mesothelial cells form a layer covering Glisson’s capsule but are not present in the liver parenchyma physiologically. Although evidence concerning the origin of liver mesothelioma is unclear, considering the subcapsular location in the majority of cases, many authors have speculated that it originates from Glisson’s capsule and eventually invades the liver [4].

A review of the literature (Table 1) revealed that age at diagnosis ranged from 36 to 70 years (mean: 58 years). Of the diagnosed cases, 62.5% were male and 37.5% were female, showing a slight male preponderance. One case described by Imura et al. was associated with cirrhosis due to hepatitis C infection [5]. Another patient diagnosed with biphasic type mesothelioma had a history of asbestos exposure, making our case the second in the literature to be associated with asbestos exposure. Although there is an association between asbestos and pleural and peritoneal mesothelioma, the association with hepatic mesothelioma is still unclear [6].

Table 1.

List of publications to date

Year Age (years) Sex Size (cm) Asbestos exposure Lobe involved Histology Symptoms Outcome
Imura et al.(5) 2002 64 M 3.2 No Right Epithelioid Incidental finding No recurrence 40 months after surgery
Leonardou et al. (10) 2003 54 M 16 N/A Right Epithelioid Abdominal pain No recurrence 60 days after surgery
Di Blasi et al.(11) 2004 61 M 10 N/E Right Epithelioid Weakness and mild abdominal pain Metastasis in inguinal lymph nodes and pelvic peritoneum 3 years after surgery
Gütgemann et al. (8) 2006 62 M 5.8 No Right Epithelioid Non-specific upper abdominal discomfort Metastasis to periaortic and thoracic lymph nodes 5, 12 and 20 months after surgery
Kim et al.(12) 2008 53 M 13 No Right Epithelioid Incidental finding Local recurrence and diaphragm invasion 15 and 23 months after surgery
Sasaki et al.(6) 2009 66 M 4 Yes Right Biphasic RUQ pain with weight loss No recurrence at 6-month follow-up
Inagaki et al.(13) 2013 68 F 7 No Right Epithelioid Prolonged low-grade fever Rapid growth of tumour complicated by hepatic rupture, 3-month survival
Dong et al.(14) 2014 50 F Multiple No Bilateral Epithelioid RUQ pain N/A
Perysinakis et al. (15) 2014 66 M 17 No Right Epithelioid Weakness, incidental finding No recurrence 36 months after surgery
Serter et al.(16) 2014 56 F 15 No Right Epithelioid Abdominal pain and weakness Intraoperative peritonitis, carcinomatosis with omental cake
Serter et al.(16) 2014 66 M 14 No Left (lateral segment) Biphasic Abdominal pain and weight loss Direct invasion to stomach and tail of pancreas
Ali et al.(9) 2016 41 F 21 No Right Biphasic RUQ pain, weight loss, low-grade fever N/A
Minami et al.(17) 2017 36 F 13 No Right Epithelioid Abdominal and back pain Intraoperative direct omental invasion. No recurrence at 6 months
Ismael et al.(4) 2018 60 M 11.3 No Right Epithelioid RUQ pain, weight loss N/A
Wong et al.(18) 2019 55 F 18 No Right Epithelioid Non-specific abdominal pain No recurrence 8 years after surgery
Present case 2019 70 M 8 Yes Right Epithelioid Incidental finding No recurrence 15 months after surgery

Clinically, the majority of patients present with non-specific symptoms such as abdominal pain, weight loss and low-grade fever. In 25% (4/16) of cases, and in our patient, PIHMM was detected as an incidental finding of a localized subcapsular nodular lesion in the right lobe. The average diameter of the tumour was 11 cm (3.2–21 cm). CT scanning with contrast was the imaging modality of choice in all cases. In the majority of cases, it presented as a well-circumscribed tumour with abnormal heterogenous enhancement and areas of necrosis and haemorrhage. Post-contrast enhancement of peripheral serpiginous vascular structure and septal enhancement was also noted.

Histologically, malignant mesothelioma can be divided into three different types: epithelioid, sarcomatoid and biphasic (a mixture of epithelioid and sarcomatoid). Epithelioid is the most common type and can be tubulopapillary or solid and surrounded by either desmoplastic stroma or mixed inflammatory infiltrates.

The clinician should keep in mind other primary and secondary tumours such as hepatocellular carcinoma, cholangiocarcinoma and a metastasized adenocarcinoma when investigating malignant mesothelioma of the liver. Immunohistochemistry helps in the definitive diagnosis of the tumour. A mesothelial origin was proven by positive calretinin, WT-1, cytoplasmic D2–40, cytokeratins, CK AE1/AE3, thrombomodulin staining and negative CD34, Ber-EP4, MOC-31, CEA, AFP and CA-19-9[1,3]. Calretinin, a 29-kDa protein that belongs to a family of calcium-binding proteins, is highly sensitive and specific in diagnosing epithelioid mesothelioma [7, 8].

Treatment is with surgical removal of the tumour and the attached portion of the. Some 37.5% (6/16) of cases reported in the literature showed invasion beyond their original site, metastasis or local recurrence, while 37.5% (6/16) of cases had no recurrence after surgery [4, 9].

CONCLUSION

Primary malignant mesotheliomas are rare tumours detected as well-circumscribed, subcapsular lesions particularly in the right lobe of the liver. Due to the limited number of described cases, the association between asbestos exposure and hepatic mesothelioma is still unclear. Hence, more cases should be reported, while asbestos exposure is kept in mind, to provide a clear understanding. This diagnosis should be considered in the evaluation of liver mass.

Footnotes

Conflicts of Interests: The Authors declare that there are no competing interests.

REFERENCES

  • 1.Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34(7):1413–9. doi: 10.1093/carcin/bgt166. [DOI] [PubMed] [Google Scholar]
  • 2.Ghimire S, Yang T, Shah H, Srivatana U, Sarker A. primary malignant mesothelioma of liver: a rare liver tumor. Am J Gastroenterol. 2019;114(1):S1257–S1257. [Google Scholar]
  • 3.Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review. Ann Transl Med. 2017;5(11):236. doi: 10.21037/atm.2017.03.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ismael H, Cox S. Primary intrahepatic mesotheliomas: A case presentation and literature review. Int J Surg Case Rep. 2018;47:1–6. doi: 10.1016/j.ijscr.2018.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Imura J, Ichikawa K, Takeda J, Iwasaki Y, Tomita S, Kubota K, et al. Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: A case report with review of the literature. APMIS. 2002;110(11):789–94. doi: 10.1034/j.1600-0463.2002.t01-1-1101102.x. [DOI] [PubMed] [Google Scholar]
  • 6.Sasaki M, Araki I, Yasui T, Kinoshita M, Itatsu K, Nojima T, et al. Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis. World J Gastroenterol. 2009;15(5):615–21. doi: 10.3748/wjg.15.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim H, Damjanov I. Localized fibrous mesothelioma of the liver. Report of a giant tumor studied by light and electron microscopy. Cancer. 1983;52(9):1662–5. doi: 10.1002/1097-0142(19831101)52:9<1662::aid-cncr2820520919>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 8.Gütgemann I, Standop J, Fischer HP. Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch. 2006;448(5):655–8. doi: 10.1007/s00428-006-0175-8. [DOI] [PubMed] [Google Scholar]
  • 9.Haji Ali R, Khalife M, El Nounou G, Zuhri Yafi R, Nassar H, Aidibe Z, et al. Giant primary malignant mesothelioma of the liver: A case report. Int J Surg Case Rep. 2017;30:58–61. doi: 10.1016/j.ijscr.2016.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Leonardou P, Semelka RC, Kanematsu M, Braga L, Woosley JT. Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging. 2003;21(9):1091–3. doi: 10.1016/s0730-725x(03)00197-8. [DOI] [PubMed] [Google Scholar]
  • 11.Di Blasi A, Boscaino A, De Dominicis G, Marsilia GM, D’Antonio A, Nappi O. Multicystic mesothelioma of the liver with secondary involvement of peritoneum and inguinal region. Int J Surg Pathol. 2004;12(1):87–91. doi: 10.1177/106689690401200116. [DOI] [PubMed] [Google Scholar]
  • 12.Kim DS, Lee SG, Jun SY, Kyoung WK, Ha TY, Kim KK. Primary malignant mesothelioma developed in liver. Hepatogastroenterology. 2008;55:1081–1084. [PubMed] [Google Scholar]
  • 13.Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature. Oncol Lett. 2013;6(3):676–80. doi: 10.3892/ol.2013.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dong A, Dong H, Zuo C. Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT. Clin Nucl Med. 2014;39(7):619–22. doi: 10.1097/RLU.0b013e31828da61d. [DOI] [PubMed] [Google Scholar]
  • 15.Perysinakis I, Nixon AM, Spyridakis I, Kakiopoulos G, Zorzos C, Margaris I. Primary intrahepatic malignant epithelioid mesothelioma. Int J Surg Case Rep. 2014;5(12):1098–101. doi: 10.1016/j.ijscr.2014.11.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Serter A, Buyukpinarbasili N, Karatepe O, Kocakoc E. An unusual liver mass: primary malignant mesothelioma of the liver: CT and MRI findings and literature review. Jpn J Radiol. 2014;33(2):102–6. doi: 10.1007/s11604-014-0379-9. [DOI] [PubMed] [Google Scholar]
  • 17.Minami K, Okumura H, Hiwatashi K, Matsukita S, Setoyama T, Minamimagari K, et al. Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature. Surg Case Reports. 2017;3(1) doi: 10.1186/s40792-017-0342-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wong S, Gargi D, Cha C, Klimstra D, Jain D. Primary mesothelioma of the iver: a case report. Ajsp Rev Reports. 2019;24(4) [Google Scholar]

Articles from European Journal of Case Reports in Internal Medicine are provided here courtesy of European Federation of Internal Medicine

RESOURCES